Trilostane for Androgen-Independent Prostate Cancer
Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to test the safety of trilostane by looking at what
effects, good and bad, it has on patients with androgen-independent prostate cancer.